Sudarshan Chemical Industries Ltd
Sudarshan Chemical Industries Q2 Results 2026 (FY27) investor presentation: Revenue & Margins
Q2 FY27 investor presentation: what the company reported on revenue, margins and capex.
- Revenue
- ₹2,743Cr
- Net profit
- ₹31Cr
- Margin
- 9.7%
Guidance rank: #54 of 70 in Chemicals & Petrochemicals
See the sector's top 10 — free with your mobile number.
Based on Sudarshan Chemical Industries Ltd's Q2 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Q2 FY27 Revenue from Operations:. Quarter EBITDA (Q2 FY27):.
From Sudarshan Chemical Industries Ltd's Q2 FY27 earnings-call transcript · updated 6 Nov 2026.
How did Sudarshan Chemical Industries' revenue grow in the September 2026 quarter?
- Q2 FY27 Revenue from Operations:
- One Sudarshan: ₹ 868 Cr, up 22.0% YoY (Q2 FY26: ₹ 712 Cr) [Page 20]
- Legacy Sudarshan: ₹ 1,962 Cr, up 14.9% YoY (Q2 FY26: ₹ 1,683 Cr) [Page 20]
- Acquired Group: ₹ 868 Cr, up 22.0% YoY (Q2 FY26: ₹ 712 Cr) [Page 20]
- Sales figures (H1 FY27):
- One Sudarshan consolidated: ₹ 5,385 Cr, up 10.0% YoY (H1 FY26: ₹ 4,894 Cr) [Page 21]
- Legacy Sudarshan: ₹ 3,935 Cr, up 10.4% YoY (H1 FY26: ₹ 3,565 Cr) [Page 21]
- Acquired Group: ₹ 1,636 Cr, up 22.1% YoY (H1 FY26: ₹ 1,340 Cr) [Page 21]
- Outlook:
2 more points from Sudarshan Chemical Industries Ltd's call on revenue
Create a free account to keep reading this call
What happened to Sudarshan Chemical Industries' margins in Q2 FY27?
See what Sudarshan Chemical Industries Ltd said on profitability & margins — free account, 30 seconds.
What capex is Sudarshan Chemical Industries planning?
- The presentation mentions two late-stage projects at RIECO facing cost overruns, fully accounted for in the quarter (Page 19).
- A notable non-core asset transaction: sale of Diketene & CKP Plant (VP4 Frankfurt GmbH) completed Nov 2, 2026, with proceeds of €75.8 Mn, primarily to prepay acquisition debt strengthening the balance sheet (Page 13).
- Integration work including SAP and GCC systems is progressing well, supporting profit synergies (Page 24).
2 more points from Sudarshan Chemical Industries Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Is Sudarshan Chemical Industries raising money or cutting debt?
See what Sudarshan Chemical Industries Ltd said on fundraising & capital structure — free account, 30 seconds.
How big is Sudarshan Chemical Industries' order book?
See what Sudarshan Chemical Industries Ltd said on order book & pipeline — free account, 30 seconds.
Sudarshan Chemical Industries Ltd — Quarterly revenue & net profit
Q2 FY27 figures are not in this chart yet. Latest shown: Jun 2026 (Q1 FY27). The Q2 FY27 numbers from the filing are in the table below.
Sudarshan Chemical Industries Ltd Q2 FY27 results — key figures
| ₹ Cr | Q2 FY27 |
|---|---|
| Revenue | 2,743 |
| Operating profit (EBITDA) | 267 |
| Operating margin | 9.7% |
| Profit before tax | 64 |
| Net profit (PAT) | 31 |
| EPS (₹) | 13.94 |
Source: Sudarshan Chemical Industries Ltd's results filing to NSE (consolidated), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q1 FY27): revenue ₹2.6K Cr, net profit ₹103 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Sudarshan Chemical Industries's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Anupam Rasayan India Ltd (Q2 FY27)
Q2 FY27 consolidated revenue: ₹821 Cr, up 12% YoY (₹731 Cr in Q2 FY26 including one-off sales of ₹180 Cr) . Key investor presentation takeaways from Anupam Rasa
- Laxmi Organic (Q2 FY27)
Q2FY27 Revenue from operations: INR 10,827 Mn, up 54.7% year-on-year (Q2FY26: INR 6,997 Mn) . Key investor presentation takeaways from Laxmi Organic Industries
- Kiri Industries Ltd (Q2 FY27)
Q2-FY27 Consolidated Revenue from Operations: INR 2,882 million, up 48.1% YoY from INR 1,946 million in Q2-FY26 (Page 13). Key investor presentation takeaways f
- Excel Industries (Q2 FY27)
Q2 FY27 Revenue from Operations (Standalone): ₹274.6 Cr, up 1.6% YoY (Page 11) . Key investor presentation takeaways from Excel Industries Ltd's Q2 FY27 investo
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Sudarshan Chemical Industries Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Sudarshan Chemical Industries Ltd Q2 FY27 results?
Q2 FY27 Revenue from Operations:. Quarter EBITDA (Q2 FY27):.
What is Sudarshan Chemical Industries Ltd share price analysis?
Sudarshan Chemical Industries Ltd currently shows a neutral. The stock trades at a P/E of 85.1 with a market cap of ₹8,639 Cr. Investors should review the full earnings analysis for detailed insights.
Is Sudarshan Chemical Industries Ltd planning capital expenditure?
The presentation mentions two late-stage projects at RIECO facing cost overruns, fully accounted for in the quarter (Page 19).
Keep Sudarshan Chemical Industries Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.